Long-term treatment of primary pulmonary hypertension with aerosolized iloprost, a prostacyclin analogue;Langfristige behandlung der primären pulmonalen hypertonie mit inhalativem iloprost

Pneumologie

Volumn 55, Issue 1, 2001, Pages 38-43

  Hoeper, M M ^a   Schwarze, M ^a   Ehlerding, S ^a   Adler Schuermeyer, A ^a   Spiekerkoetter, E ^a   Niedermeyer, J ^a   Hamm, M ^a   Fabel, H ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ILOPROST; PROSTACYCLIN DERIVATIVE;

ADULT; AEROSOL; AGED; ARTICLE; CENTRAL VENOUS CATHETER; CLINICAL ARTICLE; CONTINUOUS INFUSION; DRUG EFFECT; EXERCISE TOLERANCE; FEMALE; HEART OUTPUT; HEMODYNAMIC MONITORING; HUMAN; LUNG ARTERY PRESSURE; LUNG HEMODYNAMICS; LUNG VASCULAR RESISTANCE; MALE; PRIORITY JOURNAL; PULMONARY HYPERTENSION;

ADMINISTRATION, INHALATION; ADULT; AGED; EXERCISE TEST; FEMALE; FOLLOW-UP STUDIES; HEMODYNAMIC PROCESSES; HUMANS; HYPERTENSION, PULMONARY; ILOPROST; LONG-TERM CARE; MALE; MIDDLE AGED;

EID: 0035133033     PISSN: 09348387     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2001-10443     Document Type: Article

References (21)

1. Long-term treatment of primary pulmonary hypertension with continuous intravenous epoprostenol (prostacyclin)
2. Treatment of pulmonary hypertension with infusion of prostacyclin (epoprostenol)
3. Survival in primary pulmonary hypertension with long-term continuous intravenous prostacyclin
4. A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension
5. Primary pulmonary hypertension: Improved long-term effects and survival with continuous intravenous epoprostenol infusion
6. Effect of long-term infusion of prostacyclin (epoprostenol) on echocardiographic measures of right ventricular structure and function in primary pulmonary hypertension
7. Reduction in pulmonary vascular resistance with long-term epoprostenol (prostacyclin) therapy in primary pulmonary hypertension
8. Iloprost. A review of its pharmakodynamic properties, and therapeutic potential in peripheral vascular disease, myocardial ischemia and extracorporeal circulation procedures
9. Aerosolized prostacyclin and iloprost in severe pulmonary hypertension
10. Inhaled iloprost to treat severe pulmonary hypertension: An uncontrolled trial
11. A comparison of the acute hemodynamic effects of inhaled nitric oxide and aerosolized iloprost in primary pulmonary hypertension
12. Inhaled prostacyclin and iloprost in severe pulmonary hypertension secondary to lung fibrosis
13. Primary pulmonary hypertension: A national prospective study
14. The 6-minute walk: A new measure of exercise capacity in patients with chronic heart failure
15. Determination of cardiac output by Fick's method, thermodilution, and acetylene rebreathing in pulmonary hypertension
16. Prostaglandins induce vascular endothelial growth factor in a human monocygotic cell line and in rat lungs via cAMP
17. Pulmonary hypertension - Beyond vasodilator therapy
18. Epoprostenol (prostacyclin) and pulmonary hypertension
19. Comparison of two inhalation systems for ilomedin-aerosol therapy in pulmonary hypertension
20. Primary pulmonary hypertension